Skip to main content
. 2022 Feb;33(2):401–419. doi: 10.1681/ASN.2021050643

Table 3c.

Time to treatment failure: During the follow-up period

Group No. of Patients No. of Patients with Treatment Failure No. of Patients Censored Median (95% CI) (days) Hazard Ratio (95% CI)
MMF 33 17 16 386.0 (224.0 to 794.0) 2.598 (0.87 to 7.75)
Placebo 17 4 13 not reached (278.0 to not reached)